about
Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodiesExtended O-GlcNAc on HLA Class-I-Bound Peptides.Avian and Human Seasonal Influenza Hemagglutinin Proteins Elicit CD4 T Cell Responses That Are Comparable in Epitope Abundance and DiversityGlycans Instructing Immunity: The Emerging Role of Altered Glycosylation in Clinical Immunology.Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity.Mycobacterial infection induces a specific human innate immune response.Chemical Methods for Encoding and Decoding of Posttranslational ModificationsChanges in total plasma and serum N-glycome composition and patient-controlled analgesia after major abdominal surgery.GlycoMine(struct): a new bioinformatics tool for highly accurate mapping of the human N-linked and O-linked glycoproteomes by incorporating structural features.Control of lung defence by mucins and macrophages: ancient defence mechanisms with modern functions.Localized Chemical Remodeling for Live Cell Imaging of Protein-Specific Glycoform.Label-Free Detection of Glycan-Protein Interactions for Array Development by Surface-Enhanced Raman Spectroscopy (SERS).Adaptable synthesis of C-lactosyl glycoclusters and their binding properties with galectin-3.A Human Lectin Microarray for Sperm Surface Glycosylation Analysis.Carbohydrates as T-cell antigens with implications in health and disease.Lipopeptides: a novel antigen repertoire presented by major histocompatibility complex class I molecules.N-O linkage in carbohydrates and glycoconjugates.Interchangeability of Biosimilars: A European Perspective.An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity.Vaccination against Salmonella Infection: the Mucosal Way.Design, automated synthesis and immunological evaluation of NOD2-ligand-antigen conjugatesA method to identify trace sulfated IgG N-glycans as biomarkers for rheumatoid arthritis.Protein O-fucosylation in Plasmodium falciparum ensures efficient infection of mosquito and vertebrate hosts.Unfolded protein response signaling impacts macrophage polarity to modulate breast cancer cell clearance and melanoma immune checkpoint therapy responsiveness.Systematic and site-specific analysis of N-sialoglycosylated proteins on the cell surface by integrating click chemistry and MS-based proteomics.Crystal structures of H-2Db in complex with the LCMV-derived peptides GP92 and GP392 explain pleiotropic effects of glycosylation on antigen presentation and immunogenicity.Animal Cell Expression Systems.Computer aided epitope design as a peptide vaccine component against Lassa virus.Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemia.Principles of mucin structure: implications for the rational design of cancer vaccines derived from MUC1-glycopeptides.Core Fucosylation of the T Cell Receptor Is Required for T Cell Activation.IgG Glycome in Colorectal Cancer.Identification and Characterization of Complex Glycosylated Peptides Presented by the MHC Class II Processing Pathway in Melanoma.High polymorphism in MHC-DRB genes in golden snub-nosed monkeys reveals balancing selection in small, isolated populations.Biodegradable Chitosan Decreases the Immune Response to Trichinella spiralis in Mice.A novel B- and helper T-cell epitopes-based prophylactic vaccine against Echinococcus granulosus.Charge and Polarity Preferences for N-Glycosylation: A Genome-Wide In Silico Study and Its Implications Regarding Constitutive Proliferation and Adhesion of Carcinoma Cells.An enrichment method based on synergistic and reversible covalent interactions for large-scale analysis of glycoproteins.Single-pot glycoprotein biosynthesis using a cell-free transcription-translation system enriched with glycosylation machinery.A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection
P2860
Q26314715-7070A0BC-B0BD-4C8D-ACE5-4CFFF17C50A4Q30356689-42F233B4-FB57-4822-BC9D-76DB514A2F1CQ30397672-CFCC5139-1262-42C1-8FA9-0B27D0422963Q35725275-C1F89DF1-3F52-457F-9991-62D3EBBB5020Q36281860-F120344E-51D4-4D29-BADE-2EB4D9582F5EQ36301100-3AEE874B-D093-4D6F-A65F-D4C00546A7B5Q36654176-19E86C96-3EAA-4194-AB60-A84573A7A467Q37159904-1C0E3287-8C76-4DC2-A2AF-FB7D5678D008Q37314730-4A69B93F-7887-4CAB-B348-2BAC82D6AFCFQ37431918-9AE3E22B-EFE6-4B1E-9EE6-A3C1ECDAD448Q38288036-FF6AF9E1-5D3A-47C6-ABB4-77643C0ADFA4Q38292044-47995E29-45B2-490F-8202-AD44992DEE69Q38304497-433A3215-2F60-4F84-851B-6DEE4AA249E0Q38760617-6B51B101-5CC7-4612-B86B-6164A38DF7D8Q38847198-7EE6FD82-0CAA-49C0-AF39-4FBFF3CD3659Q38893422-80FE53E4-8C42-4BEB-8878-1B413236060AQ38995811-A408CDED-73DE-4BA7-9C84-4901D8D587D3Q39000780-CD11E63F-DBDF-48AA-BB4F-ACF5DB9856DDQ39093233-E073F020-6B76-4304-BDE9-DB479855C934Q39373957-314C526E-DB81-4CBC-A6B2-7EB9E4EC6320Q41587023-0948281A-3765-419C-A9E9-56046C10BD1BQ41701035-C1D9F980-DFA4-4070-972A-7F1D6DDD42CFQ41701401-11210644-94F4-46CD-BC41-FE0006061682Q44964898-299955C0-EAC8-49B6-88B3-C0B2E66BA476Q46030765-0CDA341E-ECCB-4179-8027-D46C3C709032Q47144276-8E099A01-C226-4DF0-BE36-B47D6A535C50Q47406183-D7E9BC05-5B23-43CD-AB58-B9D838C7C5C1Q47548092-6168B896-5E21-4098-A9F8-1E99F144A6B8Q47818563-E1ADFBE4-B141-4C45-B627-4CB307AB4CC2Q47902181-8B97E530-B3B9-4C3D-AB7D-973113D5CCAFQ49520509-35195B0C-F3FD-41C9-99DF-B086854E0B0FQ50856757-EAD3F176-AAB1-4194-870D-58592EC5AE92Q51556710-9EFB86D6-C3C4-4B25-B504-C15B09C8FA48Q51740685-F7E3305B-EAFF-4457-869A-E88362C55CCBQ54314018-B09BBCF1-F551-4773-94E1-A97B5A4745BFQ54963598-4D87371C-7717-44E5-99ED-ADBE61C6C510Q54985550-27538335-5511-4E50-9660-B696153CEC88Q55005205-ADFD20A8-7996-4106-9904-258867B74A1AQ55689952-ED182C10-130E-4CD4-81CC-F198CABE3799Q57072187-DA89D971-B28F-4C47-BF8D-4771C1167091
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adaptive immune activation: glycosylation does matter.
@en
Adaptive immune activation: glycosylation does matter.
@nl
type
label
Adaptive immune activation: glycosylation does matter.
@en
Adaptive immune activation: glycosylation does matter.
@nl
prefLabel
Adaptive immune activation: glycosylation does matter.
@en
Adaptive immune activation: glycosylation does matter.
@nl
P2860
P356
P1476
Adaptive immune activation: glycosylation does matter.
@en
P2860
P2888
P304
P356
10.1038/NCHEMBIO.1403
P577
2013-12-01T00:00:00Z